Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Jun 25, 2019 at 11:45 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 29, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

The top analyst upgrades, downgrades and initiations seen on Monday included AbbVie, Adobe, American Express, Intel, 3M, Microsoft, SAP, Shopify,…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 19, 2019 at 10:25 AM EDT

Bad News for AbbVie and Multiple Myeloma Patients

AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA.

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 22, 2019 at 10:05 AM EST

Why This New Collaboration Is Incredible for Voyager Therapeutics

Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.

Chris Lange | Feb 12, 2019 at 9:35 AM EST

Major Pharma Scares Off Short Sellers

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 30, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Apple, Carnival, Ciena, Juniper Networks, Lockheed Martin, Plug…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

1 … 15 16 17 18 19 … 38

AbbVie : ABBV

All AbbVie Articles

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Bad News for AbbVie and Multiple Myeloma Patients

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Why This New Collaboration Is Incredible for Voyager Therapeutics

Major Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

AbbVie : ABBV

All AbbVie Articles

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Bad News for AbbVie and Multiple Myeloma Patients

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Why This New Collaboration Is Incredible for Voyager Therapeutics

Major Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Allergan, Apple, Carnival, Ciena, Juniper, Lockheed Martin, Plug Power, Take-Two, United Continental, Zynga and More

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do